PPARGC1A and fatty liver disease: In our study, supplementation with the precursor of NAD+, NR, prevented hepatic steatosis induced by Nic plus HFCS (Coke), involving specific molecular signaling downstream of NAD+, Sirt1, and PGC1α, to reverse mitochondrial damage.